Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-03 Machado Patrick Director Grant or award · Share Option (Right to Buy) +10,507 10,507
2026-06-03 Machado Patrick Director Grant or award · Restricted Share Units +1,593 1,593
2026-06-01 Machado Patrick Director Exercise or conversion +2,645 2,645
2026-06-01 Machado Patrick Director Exercise or conversion · Restricted Share Units −2,645 0
2025-06-05 Machado Patrick Director Grant or award · Share Option (Right to Buy) +17,012 17,012
2025-06-05 Machado Patrick Director Grant or award · Restricted Share Units +2,645 2,645
2024-06-05 Machado Patrick Director Grant or award · Stock Option (Right to Buy) +15,542 15,542
2023-06-02 Machado Patrick Director Grant or award · Stock Option (Right to Buy) +18,475 18,475
2022-06-28 Machado Patrick Director Grant or award · Stock Option (Right to Buy) +18,000 18,000
2021-06-03 Machado Patrick Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-11-05 Machado Patrick Director Grant or award · Stock Option (Right to Buy) +20,000 20,000

Page 1 of 1 · 11 trades